Frontiers in Oncology · 2022 · 13 citations · 29 references
PharmacyBiotechnologyOncologyBiomaterialsNanomaterialsNanoparticle Drug DeliveryCancer NanomedicineInorganic NanoparticlesNanocarriers For TherapeuticsNanomaterials For Drug DeliveryNanomedicineNanoparticle FormulationsAnticancer ActivityCancer NanotherapyIron Oxide NanoparticlesPoly(lactic-co-glycolic Acid)Poly(lactic-co-glycolic Acid) NanoparticlesReactive Oxygen Species HomeostasisTheranostic NanomaterialsTumor-targeted Drug Delivery
To overcome the challenges of the low efficiency of artemisinin (ART) in anticancer therapy due to its poor water solubility and poor bioavailability, we constructed folate (FA)-modified erythrocyte membrane (EM)-camouflaged poly (lactic-co-glycolic acid) (PLGA) nanoparticles (NPs) (PFH/ART@PLGA/Fe 3 O 4 -eFA). Specifically, the inner core of these NPs is mainly composed of phase-changeable perfluorohexane (PFH), magnetic Fe 3 O 4 and ART. In vitro experiments showed that the prepared PFH/ART@PLGA/Fe 3 O 4 -eFA was readily taken up by 4T1 cancer cells. PFH/ART@PLGA/Fe 3 O 4 -eFA was exposed to low-intensity focused ultrasound (LIFU) irradiation to induce PFH phase transition and NPs collapse, which promoted the release of ART and Fe 3 O 4 . After LIFU irradiation, the proportion of dead 4T1 cells, the level of reactive oxygen species (ROS) and the concentration of intracellular Fe 2+ ions in the PFH/ART@PLGA/Fe 3 O 4 -eFA group were much higher than those in the other group, indicating that the synergistic effect between the intracellular Fe 2+ ions and the released ART played a critical role in tumor cell ferroptosis by enhancing ROS generation in vitro . We demonstrated that FA-modified EM NPs could enhance the targeting and accumulation of the NPs at the tumor site in vivo . After LIFU irradiation at 3 W/m 2 for 7 min, tumor growth was completely suppressed through FA-modified EM NPs collapse and the release of ART and Fe 3 O 4 , which exerted synergistic effects in inducing tumor ferroptosis. Because of these characteristics, these NPs are considered as a promising approach for the delivery of drugs with poor water solubility for efficient cancer therapy.
29